Erythromycin ethylsuccinate crystalline hydrate, preparation and uses thereof
US9221862B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Inventor
Key dates
| Filing date | Apr 20, 2012 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | Apr 24, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-infective drug-macrolide derivate, preparation and uses thereof. Macrolide derivate, namely erythromycin ethylsuccinate crystalline hydrate. Preparation of erythromycin ethylsuccinate crystalline hydrate medicaments for the treatment and prevention of human or animal infectious diseases caused by Gram-positive or negative bacteria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.